Associated Papers
Common and Rare Genetic Risk Factors Converge in Protein Interaction Networks Underlying Schizophrenia.
Chang X et al.
Frontiers in Genetics, 2018
30323833 (PubMed )
Supplement: Table_1.xlsx › Sheet1
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L et al.
Nature Medicine, 2017
29131160 (PubMed )
Supplement: NIHMS74480-supplement-Supplementary_Dataset_4.xlsx › S11_CC-2_coding_SNVs
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_2_late_met_3
Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts.
Kemper K et al.
Embo Molecular Medicine, 2015
26105199 (PubMed )
Supplement: emmm0007-1104-sd1.pdf
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia.
Xu B et al.
Nature Genetics, 2012
23042115 (PubMed )
Supplement: NIHMS410678-supplement-5.xls › suppl_table_2
Exome sequencing supports a de novo mutational paradigm for schizophrenia.
Xu B et al.
Nature Genetics, 2011
Select a paper to view details